
Sign up to save your podcasts
Or
In our first conversation with Deep Genomics, Theral sits down with Brendan Frey, the company's founder and Chief Innovation Officer, to explore the power of AI in RNA biology and drug discovery. Frey, a pioneer in deep learning who trained in the lab of AI luminary Geoffrey Hinton, shares how his personal experience in genetics back in 2002 led him to merge machine learning with genomic medicine. The company has a head start.
In the past year, Deep Genomics has built Big RNA, the first foundational model for RNA biology, trained on over a trillion genomic signals.
"RNA is the ideal point of intervention," says Frey. "It’s the software of biology—it takes context into account, shaping how DNA functions across different cells and conditions."
4.5
3131 ratings
In our first conversation with Deep Genomics, Theral sits down with Brendan Frey, the company's founder and Chief Innovation Officer, to explore the power of AI in RNA biology and drug discovery. Frey, a pioneer in deep learning who trained in the lab of AI luminary Geoffrey Hinton, shares how his personal experience in genetics back in 2002 led him to merge machine learning with genomic medicine. The company has a head start.
In the past year, Deep Genomics has built Big RNA, the first foundational model for RNA biology, trained on over a trillion genomic signals.
"RNA is the ideal point of intervention," says Frey. "It’s the software of biology—it takes context into account, shaping how DNA functions across different cells and conditions."
32,260 Listeners
26,462 Listeners
1,034 Listeners
16,101 Listeners
9,202 Listeners
122 Listeners
11,772 Listeners
5,937 Listeners
5,397 Listeners
88 Listeners
29 Listeners
88 Listeners
147 Listeners
15,237 Listeners
92 Listeners